An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study.
about
Fentanyl for chronic painFentanyl for chronic painBreakthrough cancer pain: review of prevalence, characteristics and managementRecent advances in the use of opioids for cancer painEpisodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care.Nasal administration of opioids for pain management in adults.Pharmacotherapy of cancer-related episodic pain.Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications.Fentanyl nasal spray for the treatment of cancer pain.Fentanyl for breakthrough pain: a systematic review.Intranasal fentanyl in the treatment of acute pain--a systematic review.Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care.Pharmacological Management of Cancer-Related Pain.Fentanyl Formulations in the Management of Pain: An Update.Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.Role of intranasal fentanyl in breakthrough pain management in cancer patients.Recent development in therapeutics for breakthrough pain.Is morphine still the best reference opioid?Intranasal sufentanil for cancer-associated breakthrough pain.Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis.
P2860
Q24203830-6097DF5A-B5DE-4EEF-84B2-DA85556F43C5Q24242219-E744DBB0-F34C-41FF-919D-49E742A0542AQ24633771-6AE7187C-E496-49A2-BF00-D8A40472B803Q34418203-EDC1F218-C6BF-4088-AC3E-E3860E609BC3Q34539972-ADE34D37-6AE4-412B-8566-68C89A759C47Q34760508-304FCD6C-DF21-4A4A-A5D6-6974ADFF0D8BQ35095194-4A9C8FE1-2EEA-4A81-B73D-8AD337DE17E1Q37774349-45CB5562-921B-4614-965D-B44F72059069Q37879143-82F1DB0D-7144-46FC-866F-46CDA2F8E3D4Q37907299-0B714363-8498-4A4B-A3E9-C0006D3C2734Q37977122-57BD2435-C92D-4E57-A016-6CE4F548CA50Q38586530-6F8B8B4F-FBD5-441E-9371-D196C8C0C2DAQ38672359-89F73B0B-E33A-4942-8280-A3D3B6EC7208Q39197889-BDDF4769-5F36-4E6B-A0E5-21B856AF54CCQ39315334-BD2AC270-CA4A-497C-B454-47ABC616BBD7Q39801041-439244BA-82D9-428C-9F31-62BB3F40B013Q43085276-D5669ED4-C309-43F8-8947-048072390F21Q44344049-3FF09EE9-8ED6-463C-B2CA-EC1109EE0C3BQ46162572-FA58E5E3-E3FD-41DA-8737-FE6BEED47765Q53288431-B1D29FE3-5860-423A-A3D8-88DC59915DAEQ53681112-FD2E6990-CC03-4890-A3C6-9F484436885A
P2860
An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
An assessment of the safety, e ...... akthrough pain: a pilot study.
@ast
An assessment of the safety, e ...... akthrough pain: a pilot study.
@en
type
label
An assessment of the safety, e ...... akthrough pain: a pilot study.
@ast
An assessment of the safety, e ...... akthrough pain: a pilot study.
@en
prefLabel
An assessment of the safety, e ...... akthrough pain: a pilot study.
@ast
An assessment of the safety, e ...... akthrough pain: a pilot study.
@en
P1476
An assessment of the safety, e ...... akthrough pain: a pilot study.
@en
P2093
Zeppetella G
P304
P356
10.1016/S0885-3924(00)00180-9
P577
2000-10-01T00:00:00Z